A new urine test, MyProstateScore 2.0 (MPS2), can now detect aggressive prostate cancer with 94 per cent accuracy—no hospital ...

Increasing evidence suggests that cancer misinformation, especially the promotion of unverified treatments, can have serious ...

The Ashanti region in 2024 witnessed a significant surge in cancer cases, with a total increase of 4,553, which is 33.60% more cases in 2023.

The Government is “looking carefully” at introducing routine screening for prostate cancer as developments in technology are making diagnosis more effective, a health minister has said. Andrew Gwynne ...

The recent expansion of chemotherapy through the GPHC to the New Amsterdam Hospital is a welcome development. The Commission is aware that approximately 100 ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

In commemoration of World Cancer Day 2025, a cancer organization, Project PINK BLUE - Health & Psychological Trust Centre, in collaboration with the Global Colorectal Cancer Association, premiered a ...

(RTTNews) - RedHill Biopharma (RDHL) Tuesday announced that it has launched a Phase 2 trial to assess opaganib's ability to enhance darolutamide in treating metastatic castrate-resistant prostate ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, potentially improving survival and expanding treatment options. A novel approach ...

It comes as the health secretary called on experts and survivors to share their experiences to help shape the new National ...

One of the biggest challenges in cancer treatment is addressing the ability of cancer cells to adapt and become resistant, ...

For decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many cancers manage to overcome this and continue growing. Now, scientists think they ...